CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 30 filers reported holding CARDIFF ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $9,200,000 | -64.3% | 1,383,500 | -50.3% | 4.96% | -47.8% |
| Q1 2021 | $25,793,000 | -28.3% | 2,785,410 | +39.3% | 9.50% | +10.9% |
| Q4 2020 | $35,980,000 | +178.6% | 2,000,000 | +119.8% | 8.56% | +30.8% |
| Q3 2020 | $12,913,000 | +1386.0% | 910,000 | +424.9% | 6.55% | +1063.1% |
| Q2 2020 | $869,000 | – | 173,361 | – | 0.56% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 120,600 | $265,000 | 0.37% |
| Artal Group S.A. | 750,000 | $1,650,000 | 0.09% |
| XTX Topco Ltd | 55,081 | $121,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 117,295 | $258,000 | 0.04% |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | 23,800 | $52,000 | 0.03% |
| Atom Investors LP | 33,798 | $74,000 | 0.03% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 296,507 | $652,000 | 0.03% |
| Laurion Capital Management LP | 722,100 | $1,589,000 | 0.02% |
| MYDA Advisors LLC | 30,000 | $66,000 | 0.02% |
| Ergoteles LLC | 184,000 | $405,000 | 0.01% |